# Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

> **NCT03289208** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 30 (actual)

## Conditions studied

- Renal Impairment
- Healthy

## Interventions

- **DRUG:** MCI-186

## Key facts

- **NCT ID:** NCT03289208
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-27
- **Primary completion:** 2018-04-16
- **Final completion:** 2018-04-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03289208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03289208, "Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03289208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*